References
- Bafna UD, Umadevi K, Kumaran C, et al 2001. Germ cell tumours of the ovary: is there a role for aggressive cytoreductive surgery for non dysgerminomatous tumours? International Journal of Gynecological Cancer 11:300–304.
- Dark GG, Bower M, Newlands ES, et al 1997. Surveillance policy for stage I ovarian germ cell tumours. Journal of Clinical Oncology 15:620–624.
- Gershenson DM. 2007. Management of ovarian germ cell tumours. Journal of Clinical Oncology 25:2938–2943.
- Gueye A, Narducci F, Baranzelli MC, et al 2007. Malignant ovarian germ cell tumours: a trial of 36 cases. Gynécologie Obstétrique and Fertilité 35:406–419.
- Kim SK, Sohn IS, Kim JW, et al 1993. Gonadoblastoma and dysgerminoma associated with 46 XY pure gonadal dysgenesis – a case report. Journal of Korean Medical Science 8:380–384.
- Koulouris CR, Penson RT. 2009. Ovarian stromal and germ cell tumours. Seminars in Oncology 36:126–136.
- Le T, Williams K, Senterman M, et al 2007. Histopathologic assessment of chemotherapy effects in epithelial ovarian cancer patients treated with neo adjuvant chemotherapy and delayed primary surgical debulking. Gynecologic Oncology 106:160–163.
- Neely EK, Marcus R, Rosenfeld RG, et al 1993. Turner syndrome adolescents receiving growth hormone are not osteopenic. Journal of Clinical Endocrinology and Metabolism 76:861–866.
- Patterson DM, Rustin GJ. 2006. Controversies in the management of germ cell tumours of the ovary. Current Opinion in Oncology 18:500–506.
- Speroff L, Fritz MA, editors. 2005. Clinical gynecologic endocrinology and infertility. 7th ed. Philadelphia: Lippincott Williams and Wilkins. p 348–349.
- Zanetta G, Bonazzi C, Cantu M, et al 2001. Survival and reproductive function after treatment of malignant germ cell ovarian tumours. Journal of Clinical Oncology 19:1015–1020.